Citigroup’s secret move: Madrigal’s game-changing grants!

Introduction

Citigroup (NYSE: C) has embarked on strategic shifts that are quietly transforming the bank’s outlook. In the past year, Citi’s stock surged about 60%, climbing above its tangible book value for the first time in years (^[1]). This rebound reflects growing investor confidence in Citi’s turnaround under CEO Jane Fraser, who has refocused the bank on steadier businesses like wealth management and commercial lending (^[1]). One illustrative example of Citi’s influential reach is its role in capital markets – Citi’s analysts recently reiterated a bullish Buy rating on Madrigal Pharmaceuticals after the biotech secured game-changing clinical results. Citi highlighted Madrigal’s robust financial footing (a high current ratio and cash surplus) and breakthrough NASH drug data (^[2]) (^[2]), underscoring how Citi can benefit from broader market successes. This report dives into Citigroup’s fundamentals – from dividends and leverage to valuation – while exploring the “secret moves” and context behind the headline-grabbing Madrigal storyline.

Dividend Policy & History

Citigroup currently offers a moderate dividend yield of roughly 2.4%, slightly below the financial sector average (~2.7%) (^[3]). The dividend has grown cautiously in recent years. Citi held its quarterly payout at a token $0.01 for years after the 2008 crisis, then gradually rebuilt it as the bank’s health improved. Most recently, Citi increased its quarterly dividend to $0.60 per share (up 7% from $0.56) (^[3]). On an annualized basis, the payout is about $2.28 per share (^[3]). This remains well-covered by earnings – Citigroup’s dividend payout ratio is only about 33% of profits (^[3]), indicating ample cushion to maintain or grow the dividend. In 2024, Citi paid out $4.2 billion in common dividends and still retained plenty of earnings for reinvestment and buybacks (^[4]) (^[4]). In fact, total capital returned to shareholders (dividends plus buybacks) was ~$6.7 billion in 2024, representing a 58% total payout of net income (^[4]). The dividend yield has dipped lately because of Citi’s stock rally – as the share price climbed 61% year-on-year, the yield compressed from an average ~3.7% to about 2.4% (^[3]). Even so, Citi’s yield is comparable to peers like Morgan Stanley (≈2.5%) and signals a commitment to steady shareholder returns. Going forward, management has indicated a desire to maintain the $0.56+ quarterly dividend (subject to Board approval and stress test outcomes) (^[4]). With a solid earnings cover and recent Federal Reserve stress test clearance, Citi’s dividend appears sustainable. The bank also has authorization for substantial share repurchases (a new $20 billion multi-year buyback program was approved in 2025 (^[4])), which complements the dividend policy and reflects confidence in its capital position.

Leverage, Capital Structure & Coverage

Citigroup operates with a robust capital base and manageable leverage for a global bank of its size. The bank’s Common Equity Tier-1 (CET1) capital ratio stood at 13.3% as of year-end 2023 (^[5]), comfortably above regulatory minimum requirements. This ratio improved to about 13.6% by late 2024 (^[6]) as Citi accumulated capital through earnings and business exits. Citi’s Supplementary Leverage Ratio (SLR) – a broad measure of capital against total assets – is around 5.8% (^[5]) (^[6]), exceeding the 5% threshold generally expected of top-tier banks. In practical terms, Citi holds over $200 billion in Tier-1 capital and about $1.3 trillion in deposits funding its balance sheet (^[4]). Total assets are roughly $2.4 trillion, equating to ~10x asset/equity leverage, which is on par with other large money-center banks.

Debt maturities are well-distributed. Citigroup’s holding company and subsidiaries have issued substantial long-term debt to meet regulatory Total Loss-Absorbing Capacity (TLAC) requirements, with an average weighted maturity of about 7–8 years for unsecured debt (^[4]) (^[4]). For example, at end-2024 the weighted-average maturity of Citi’s unsecured long-term debt was 7.3 years, and even its TLAC-eligible bonds averaged over 8 years maturity (^[4]). This lengthy debt tenor means Citi faces no imminent refinancing crunch; near-term debt obligations are relatively small, reducing liquidity risk. Meanwhile, Citi’s liquidity profile is solid – the bank maintains over $950 billion in high-quality liquid assets and substantial excess reserves (far above regulatory liquidity coverage requirements, per its filings).

Buffett Alert

Golden Anomaly: One miner big enough for Buffett — selling at a 43% discount to tangible value.

See the name & ticker
✕

Coverage ratios for Citigroup’s obligations remain comfortable. Interest expense is well-covered by net interest income given the bank’s strong deposit franchise. Even as interest rates rose sharply, Citi managed to expand revenue from its institutional Treasury & Trade Solutions and other interest-earning businesses, which helped offset higher funding costs (^[7]). From a dividend coverage perspective, Citi’s earnings easily cover its dividends (one-third payout), and including buybacks the total payout was ~58% of 2024 profits (^[4]) – indicating a balance between rewarding shareholders and retaining capital. In short, Citigroup’s leverage is prudently managed with high capital ratios, stable deposit funding, and long debt maturities that underpin its ability to cover obligations under a range of scenarios. These strengths have been on display in regulators’ stress tests: Citi remained above required capital minimums even under severe hypothetical recessions (^[8]), though it would take a larger hit than some peers in an adverse scenario (more on that risk below).

Valuation and Peer Comparison

Despite recent stock gains, Citigroup’s valuation still lags peers on key metrics, reflecting its historically lower profitability. Citi trades around 1.0–1.1 times tangible book value per share – for context, its tangible book was about $89 per share at end of 2024 (^[6]) and the stock now hovers near that level after rising above TBV in 2025 (^[1]). This is a notable improvement; for years Citi traded at a significant discount (0.5–0.8x) to its tangible book due to investor concerns. In contrast, healthier rivals like JPMorgan have consistently traded well above book value (often ~1.5–2x TBV) thanks to superior returns on equity. Citigroup’s return on tangible common equity (RoTCE) was only ~5% in 2023, climbing to about 7% in 2024 (^[6]) – well below JPMorgan’s mid-teens RoTCE or the 10%+ that analysts consider a benchmark for book value parity. Management aims to reach a 10–11% RoTCE by 2026, which could justify a higher valuation if achieved (^[1]). Encouragingly, RoTCE improved to ~8.7% by mid-2025 as earnings grew (^[1]), and the market responded by re-rating the stock upward.

On a price-to-earnings (P/E) basis, Citi still appears inexpensive. Based on 2025 consensus earnings, Citi trades around 10–12x forward earnings, which is a discount to peers. For instance, large rivals like Bank of America and JPMorgan trade closer to 13–15x earnings (^[9]). Citi’s lower multiple mirrors its underwhelming past growth and returns. However, if Citi delivers on profit improvements (e.g., nearly $6 per share in 2024 earnings and potentially higher in 2025 (^[6])), the stock’s P/E will compress further or the price could appreciate to close the gap. Another lens is dividend yield – at ~2.4%, Citi’s yield is comparable to Morgan Stanley’s (~2.5%) but below more income-oriented banks (U.S. Bancorp is ~4% yield) (^[3]). Citi’s relatively low payout ratio suggests capacity to increase dividends faster than peers if earnings stabilize, which could attract income investors over time.

James Altucher — Your Crypto Playbook

He names the exact ticker to target in this historic U.S. Bitcoin move. Five coins. One free report.

Send Me the 5 Coins

In sum, Citigroup’s valuation reflects a mix of skepticism and turnaround potential. The stock’s price-to-tangible book (~1x) is lower than most major banks, indicating the market has not fully priced in a complete recovery (^[1]). Yet the recent rally above book value demonstrates improving sentiment as Citi executes changes. Continued progress on earnings (via cost cuts and business refocus) and clearing regulatory hurdles may unlock further upside – narrowing the valuation discount versus peers. For now, Citi offers a “value play” among big banks, trading at a modest multiple of earnings and tangible assets, but it must prove it can sustain higher returns to earn a peer-like valuation.

Risks and Red Flags

While Citigroup’s prospects are improving, several risks and red flags bear watching:

– Regulatory and Operational Compliance: Citi remains under intense regulatory scrutiny due to past control failures. It has been operating under consent orders since 2020 to fix risk-management and data systems. Progress has been costly and slower than hoped, drawing regulators’ ire. In 2020 the bank paid a $400 million fine for risk deficiencies, and as recently as mid-2023 it was fined again (over $100 million) for inadequate progress on these fixes (^[10]) (^[11]). U.S. Senator Elizabeth Warren has flagged Citi as possibly “too big to manage,” urging regulators to consider growth caps or even a breakup if Citi cannot strengthen its controls (^[10]). Such enforcement actions – for example, limits on asset growth (as was imposed on Wells Fargo) – would severely constrain Citi. Operational slip-ups have continued as well, notably an embarrassing incident where Citi accidentally wired an astronomical sum (reportedly $81 trillion) to a client due to a systems glitch (^[1]). These issues underscore ongoing operational risk. Until Citi fully satisfies regulators by upgrading its infrastructure and risk processes (targeted for 2025–26), this overhang will persist.

What's inside the FREE 2025 Wealth Protection Guide?

Why physical gold outlasts economic storms
How to move 401(k)/IRA/TSP into a Gold IRA tax-free
Privatize your retirement from market & government risk

Download the Free Guide →

– Subpar Profitability: Citi’s earnings power still trails peers, which is both a past cause and a future risk. Return on equity has been in the mid-single digits, versus double-digit norms at other big banks (^[1]). This stems from a high expense base and underperforming units. The bank is in the midst of a costly transformation program – including overhauling technology and internal controls – which keeps expenses elevated (CEO Jane Fraser noted these “transformation” costs will remain high through 2025) (^[11]). If Citi fails to materially improve its efficiency and boost ROE, investors may lose patience. The bank has already pushed out its profitability goal to 2026, acknowledging it needs more time and investment (^[1]). There’s a risk that global economic headwinds (recession, credit losses) or internal challenges could derail the targeted 10%+ RoTCE, leaving Citi stuck at a low valuation. Additionally, Citi’s revenues rely heavily on market-sensitive businesses (trading, international credit cards); volatility in those could hurt earnings consistency. In the Fed’s stress tests, Citi tends to show one of the largest capital declines under an adverse scenario, partly due to its sizable credit card and emerging-market loan exposures (^[1]). This suggests the bank could be hit harder than peers in a sharp downturn, making its capital return plans vulnerable if the economy sours.

– Franchise Simplification and Execution Risks: Citigroup is shrinking and refocusing its sprawling operations, which carries execution risk. The firm has exited consumer banking in 13 overseas markets to simplify its footprint. A major part of this plan is the spin-off of Banamex (Citi’s large Mexican retail bank). After failing to find a buyer, Citi is now preparing an IPO of Banamex, expected in 2025 after separating it from the rest of the company (^[12]). While this move could unlock value and free up capital, it’s complex and subject to market conditions as well as local regulatory approval. Any delay or setback in the Banamex separation could prolong the drag of that business on Citi’s performance. More broadly, Citi’s “transformation” involves re-organizing into five main divisions and cutting management layers. Such restructurings can disrupt operations or lead to talent attrition if not managed well. There is also strategic uncertainty in how Citi will replace the earnings of businesses it is exiting. The bank is betting on growth in Wealth Management and Treasury Services, but competition is fierce in those arenas (JPMorgan, Morgan Stanley, and others are also vying for wealthy clients and transaction banking). If Citi cannot execute in its chosen focus areas, it risks ceding ground and not meeting its growth projections.

– Macroeconomic and Credit Risks: As a globally diversified lender, Citi faces the full spectrum of macro risks. Its international presence (over 160 countries) means geopolitical or economic instability abroad can impact results – for example, Citi had to build reserves of $1.3 billion in late 2023 related to exposures in Russia and Argentina (^[5]). Rising interest rates have a mixed effect: they boost net interest income initially, but also increase funding costs and can pressure borrowers (potentially raising loan defaults). Citi has a large credit card portfolio (especially in the U.S. through its Cards unit and legacy portfolios), which is vulnerable to higher unemployment or consumer stress. Already, the bank has observed a “continued deceleration in spending” in its U.S. cards, hinting at a more cautious consumer (^[7]). Asset quality remains sound now, but in a recession scenario, losses in consumer and corporate loans could spike. Lastly, Citi’s capital markets and investment banking revenues depend on market activity – a prolonged slump in trading or deal-making would weigh on earnings (though as of mid-2025, Citi actually saw a rebound in trading and IPO advisory income (^[13]) (^[13])). Investors should monitor these external risk factors, as Citi’s turnaround hopes hinge not only on internal fixes but also on a reasonably benign macro environment.

Open Questions and Outlook

Citigroup’s “secret move” – a comprehensive overhaul to simplify the bank and boost profitability – is well underway, but several open questions remain. First, will Citi hit its performance targets by 2026? The bank now expects a 10–11% RoTCE in 2026 (^[1]), later than initially planned. Achieving this will require successful execution of cost cuts and revenue growth in core businesses. Investors are watching whether expense discipline (post-transformation) and strategic bets like wealth management yield the desired payoff. Another question is when Citi’s regulatory cloud will lift. Management asserts that expenses for risk fixes will peak by 2025 and then decline (^[11]) – implying the heavy compliance work may be largely done by then. However, Citi must demonstrate to regulators that its controls and culture have fundamentally improved. The timing of release from consent orders (and avoidance of further fines or restrictions) is uncertain. Until that chapter closes, Citi’s capital deployment could be restrained.

Moreover, the fate of Banamex and other legacy assets leaves some uncertainty. The planned IPO of Banamex in late 2025 will be a key milestone (^[12]). How much value Citi can realize from this spin-off – and whether it retains a stake – will influence its capital strength and focus going forward. Similarly, winding down the remaining “Legacy Franchises” (non-core units) is an ongoing task that may carry charges or gains. Another open question is how effectively Citi can grow its remaining businesses once the cleanup is done. There are early positive signs: in Q2 2025, Citi’s revenue grew across institutional banking, trading, and wealth management, fueling a 25% YoY profit jump (^[13]) (^[13]). Can Citi sustain this momentum in a less volatile market? The answer will determine if the bank’s re-rating in the market is durable.

Lastly, the interplay with stories like Madrigal’s “game-changing grants” highlights the broader ecosystem Citi operates in. Citi’s investment bank and research arm are positioned to capitalize on clients’ breakthroughs – whether it’s orchestrating IPOs (as Citi did with Circle and eToro in 2025 (^[13])) or endorsing emerging leaders like Madrigal in biotech. A question is how much these victories translate to Citi’s bottom line. Underwriting equity offerings, advising on deals, and providing financing to high-growth sectors could boost Citi’s fee revenues and market perception. For instance, Citi’s optimistic call on Madrigal (with a $456 price target) (^[2]) suggests confidence in that client’s success – if Madrigal’s drug is indeed a commercial breakthrough, Citi might partake in follow-on financings or advisory roles, quietly benefiting from the “game-changing” developments it helps facilitate.

In conclusion, Citigroup is at a pivotal juncture. The stock’s secret strength has been unlocked by behind-the-scenes changes and prudent capital moves, yet the true endgame – a fully revitalized, well-regarded global bank – is still in progress. If Citi can fully deliver on its transformation by tightening controls, improving returns, and smartly leveraging opportunities (perhaps those “Madrigal moments” in the market), it could shed its historical discount for good. Investors will be looking for concrete proof in upcoming quarters: better efficiency ratios, continued strong capital returns, and trouble-free regulatory exams. Until then, Citi’s journey exemplifies a work in progress – a banking giant refashioning itself while navigating risks, and occasionally making headlines in unexpected ways. The grants may be game-changing for Madrigal, but Citi’s own “secret moves” could be just as game-changing for shareholders if executed successfully.

Sources: Citigroup investor press releases and SEC filings; Reuters and Bloomberg financial news; Madrigal Pharmaceuticals investor updates; and industry analyses (^[5]) (^[1]) (^[2]) (^[3]) (^[4]) (^[4]) (^[3]) (^[10]) (^[13]). Each of these references provides factual data or credible reporting that underpins the analysis above.

Sources

For informational purposes only; not investment advice.